Semen Önder
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Pathology and Forensic Medicine top 10%
- Breast Lesions and Carcinomas
Papers in
-
- Breast Cancer Treatment Studies 21
-
- Breast Lesions and Carcinomas 22
- Co-authors
- Ekrem YavuzHasan KaranlıkGülçin YeğenNeslihan CabıoğluAbdullah İğciMahmut MüslümanoğluVahit ÖzmenMine Güllüoğlu
- Journals
- Endocrine Pathology (5 papers)The Breast Journal (4 papers)World Journal of Surgical Oncology (4 papers)Breast Care (4 papers)Archives of Gynecology and Obstetrics (2 papers)
- Partner nations
- TürkiyeUnited StatesCanada
In The Last Decade
Semen Önder
69 papers receiving 721 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 195
- Pathology and Forensic Medicine 200
- Reproductive Medicine 65
- Obstetrics and Gynecology 60
- Oncology 208
Countries citing papers authored by Semen Önder
This map shows the geographic impact of Semen Önder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Semen Önder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Semen Önder more than expected).
Fields of papers citing papers by Semen Önder
This network shows the impact of papers produced by Semen Önder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Semen Önder. The network helps show where Semen Önder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Semen Önder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 3 | |
| 13 | 2021 | 3 | |
| 14 | 2021 | 11 | |
| 15 | 2021 | 5 | |
| 16 | 2021 | 18 | |
| 17 | 2021 | 0 | |
| 18 | 2020 | 19 | |
| 19 | 2017 | 20 | |
| 20 | 1998 | 2 |
About Semen Önder
Semen Önder is a scholar working on Cancer Research, Pathology and Forensic Medicine, Reproductive Medicine, Dermatology and Obstetrics and Gynecology, having authored 80 papers that have together received 730 indexed citations. Recurring topics across this work include Breast Lesions and Carcinomas (22 papers), Breast Cancer Treatment Studies (21 papers), Cancer and Skin Lesions (11 papers), Ovarian cancer diagnosis and treatment (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Thyroid Cancer Diagnosis and Treatment (7 papers), Breast Implant and Reconstruction (6 papers) and Sarcoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Cancer Research (195 citations), Pathology and Forensic Medicine (200 citations), Reproductive Medicine (65 citations), Obstetrics and Gynecology (60 citations) and Oncology (208 citations). Semen Önder has collaborated with scholars based in Türkiye, United States and Canada. Frequent co-authors include Ekrem Yavuz, Hasan Karanlık, Gülçin Yeğen, Neslihan Cabıoğlu, Abdullah İğci, Mahmut Müslümanoğlu, Vahit Özmen, Mine Güllüoğlu, Özgür Mete and Adnan Aydıner. Their work appears in journals such as Endocrine Pathology, The Breast Journal, World Journal of Surgical Oncology, Breast Care and Archives of Gynecology and Obstetrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.